Insulet Corporation

Healthcare / Medical Devices

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Performance

--
Today 0.00 (0.00%)
PODD

Metrics

Market Cap11B
Latest Price$139.57
Previous Close$140.60
Volume1.1M
52 Week High$354.88
52 Week Low$138.79
52 Week Change-44.14%
Average Volume1.6M
Revenue2.9B
EPS4.28
P/E Ratio38.145
Forward P/E20.27
Price/Book8.681
Profit Margin0.10%
Operating Margin0.16%
Return on Equity0.23%
Dividend Yield0.00%

Recent News for PODD